{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:15:15Z","timestamp":1760296515097,"version":"3.41.2"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,9,1]],"date-time":"1998-09-01T00:00:00Z","timestamp":904608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1023\/a:1006104217137","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T19:53:09Z","timestamp":1040500389000},"page":"279-283","source":"Crossref","is-referenced-by-count":14,"title":["Phase II trial of uracil\/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Sridhar","family":"Mani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafat H.","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Sciortino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrunali","family":"Tembe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith L.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Benner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett E.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"194169_CR1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.1994.12.6.1323","volume":"12","author":"AP Venook","year":"1994","unstructured":"Venook AP: Treatment of hepatocellular carcinoma: too many options? J Clin Oncol 12: 1323-1334, 1994","journal-title":"J Clin Oncol"},{"key":"194169_CR2","first-page":"165","volume":"11","author":"YZ Patt","year":"1992","unstructured":"Patt YZ, Charnsangavej G, Lawrence D et al.: Hepatic Arterial infusion (HAI) of Fluorouracil (F), Leucovorin (L), Adriamycin (A), and Platinol (P) (FLAP): effective palliation for nonresectable Hepatocellular Cancer (HCC). Proc Am Soc Clin Oncol (abstr) 11: 165, 1992","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"11","key":"194169_CR3","first-page":"14","volume":"Suppl10","author":"Y Maehara","year":"1997","unstructured":"Maehara Y, Kakeji Y, Ohno S et al.: Scientific basis for the combination of Tegafur with uracil. Oncol (Suppl 10) 11: 14- 16, 1997","journal-title":"Oncol"},{"issue":"11","key":"194169_CR4","first-page":"35","volume":"Suppl10","author":"R Pazdur","year":"1997","unstructured":"Pazdur R: Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin. Oncol (Suppl 10) 11: 35-38, 1997","journal-title":"Oncol"},{"key":"194169_CR5","first-page":"1161","volume":"5","author":"T Taguchi","year":"1978","unstructured":"Taguchi T, Nakano H, Jikuya H et al.: Effect of uracil on the antitumor activity of Tegafur. Jpn J Cancer Chemother 5: 1161-1165, 1978","journal-title":"Jpn J Cancer Chemother"},{"key":"194169_CR6","first-page":"966","volume":"7","author":"T Taguchi","year":"1980","unstructured":"Taguchi T, Koyanna Y et al.: Phase I study of UFT. Jpn J Cancer Chemother 7: 966-972, 1980","journal-title":"Jpn J Cancer Chemother"},{"key":"194169_CR7","first-page":"1558","volume":"7","author":"O Nakajima","year":"1980","unstructured":"Nakajima O, Ihara K, Isoda T et al.: Phase I and II studies on mixture of 1-(2-tetrahydrofluorouracil)-5-fluorouracil and uracil. Jpn J Cancer Chemother 7: 1558-1568, 1980","journal-title":"Jpn J Cancer Chemother"},{"issue":"Suppl10","key":"194169_CR8","first-page":"30","volume":"11","author":"T Taguchi","year":"1997","unstructured":"Taguchi T: Experience with UFT in Japan. (Suppl 10) Oncol 11: 30-35, 1997","journal-title":"Oncol"},{"key":"194169_CR9","first-page":"333","volume":"22","author":"K Ota","year":"1988","unstructured":"Ota K, Taguchi T, Kimura K: Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22: 333-338, 1988","journal-title":"Cancer Chemother Pharmacol"},{"key":"194169_CR10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/oxfordjournals.jjco.a039083","volume":"15","author":"Tokyo Liver Cancer Chemotherapy Study Group","year":"1985","unstructured":"Tokyo Liver Cancer Chemotherapy Study Group: Phase II study of co-administration of Uracil and Tegafur (UFT) in hepatocellular carcinoma. Jpn J Clin Oncol 15: 559-562, 1985","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"194169_CR11","first-page":"124","volume":"Suppl10","author":"S Mani","year":"1997","unstructured":"Mani S: An ongoing phase II study of UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas. Oncol (Suppl 10) 11: 124-128, 1997","journal-title":"Oncol"},{"key":"194169_CR12","first-page":"141","volume":"8","author":"JA Ajani","year":"1990","unstructured":"Ajani JA, Welch SR, Raber MN et al.: Comprehensive criteria for survival in therapy-induced toxicity. Cancer Invest 8: 141-153, 1990","journal-title":"Cancer Invest"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006104217137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006104217137\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006104217137.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:47:28Z","timestamp":1753818448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006104217137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["194169"],"URL":"https:\/\/doi.org\/10.1023\/a:1006104217137","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}